
Ron Finklestien
Antero Midstream Beats Q4 Earnings Expectations
Antero Midstream Beats Q4 Earnings Expectations
Antero Midstream Corporation (AM) surprised analysts with its fourth-quarter 2023 earnings, exceeding both profit and revenue expectations. The company reported adjusted earnings per share ...
Three Overhyped Cannabis Stocks to Sell in February
Three Overhyped Cannabis Stocks to Sell in February
The AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS) has had a successful surge of nearly 30% year-to-date. This showcases the renewed demand for cannabis stocks. ...
Consolidated Edison: A Shock to Revenues
On February 16th, the public received a rude shock as shares of Consolidated Edison, Inc. (ED) took a 1% tumble, closing at $87.32. This ...
The FDA Approves Roche’s Xolair for Food Allergies, a Beacon of Hope for Allergy Sufferers
Roche has achieved a significant milestone with the FDA’s recent approval of the label expansion for Xolair (omalizumab), a drug initially intended to treat ...
Lucid Group Q4 Earnings Roundup
Lucid Group (LCID) Set to Reveal Q4 Earnings: An Insightful Preview
Lucid Group LCID is all set to unveil its fourth-quarter 2023 results on February 21, post-market. The Zacks Consensus Estimate foresees a loss of ...
PepsiCo Stock: Opportunity Knocks for Dividend Investors
PepsiCo, a stalwart in the realm of dividend aristocrats, holds its ground as a ‘Dividend King.’ The title is a testament to the company’s ...
Strategies to Navigate Sibanye Stillwater’s Stock Options (SBSW)
Strategies to Navigate Sibanye Stillwater’s Stock Options (SBSW)
It’s no secret that precious metals miner Sibanye Stillwater (SBSW) has been more of a horror show than a boon for investors. Over the ...











